Theriva Biologics
TOVX
TOVX
18 hedge funds and large institutions have $573K invested in Theriva Biologics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less capital invested
Capital invested by funds: $1.01M → $573K (-$435K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13.4K | |
| 2 | +$9.35K | |
| 3 | +$8.61K | |
| 4 |
Renaissance Technologies
New York
|
+$8.29K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$54 |
Top Sellers
| 1 | -$6.79K | |
| 2 | -$5.93K | |
| 3 | -$12 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6 |